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 Vaccination and the communist state: 
polio in Eastern Europe 
 Dora  Vargha 
 In December 1959, Hungary introduced into its national immunisation 
programme the Sabin vaccine, the live poliovirus vaccine that has been 
the tool of the Global Polio Eradication Initiative since 1988. Th is cam-
paign put Hungary in the front line of polio vaccination with live virus 
vaccines along with the Soviet Union and Czechoslovakia, where the 
Sabin vaccine was tested. Czechoslovakia became the fi rst country 
in the world to practically eradicate polio in 1960 1 and the Hungarian 
model of annual intensive mass vaccination campaigns became one 
of the bases on which the WHO built its global strategy of polio 
eradication. 2 
 How did Eastern Europe come to play such an important role in 
laying the foundations of polio eradication during the early Cold War? 
Was there something particular about Eastern European states that 
made this region especially fi tt ing or receptive to mass trials and vac-
cination campaigns that then had a global eff ect? 
 Th is chapter aims to get to the heart of this matt er by examining 
Eastern European experiences with polio in the 1950s and early 1960s. 
Two states played a particularly important part in the history of the 
Sabin vaccine, and thus stand in the focus of this analysis: Hungary and 
Czechoslovakia. Th e vaccine trials and prevention eff orts with the 
Sabin vaccine in the late 1950s and early 1960s are placed in the broader 
context of experiences with polio in Eastern Europe with the caveat that 
the description of regional vaccination policies is far from complete. 
Th e political diversity of Eastern Europe, paired with the linguistic and 
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cultural diff erences in the region make the accessibility of an overall 
Eastern European experience very challenging. Moreover, the critical 
history of vaccination programmes and public health organisation have 
been – until recently – largely unexplored, leaving historians of Eastern 
European medicine with a Herculean task when att empting to piece an 
overall narrative together. 
 In what follows, I argue that Eastern European states saw themselves, 
as they were seen by the West, to be particularly well suited to test and 
apply polio prevention with live virus vaccine on a mass scale. State 
paternalism and disease prevention as the cornerstone of communist 
public health dogmas on the one hand, and the particular organisation 
of public health practices and society more broadly on the other, con-
tributed to the region becoming a reference point in scientifi c debates 
on the use of the Sabin vaccine and on polio eradication. Although 
these ideas and concepts rooted in ideology and a Cold War view of 
Eastern European states were oft en divorced from realities, such inter-
nal and external perceptions of Eastern European states had signifi cant 
practical consequences not only in polio prevention, but also in build-
ing bridges between East and West. 
 Polio in Eastern Europe 
 To understand the signifi cance of polio in Cold War Eastern Europe, 
we must consider the social, economic and political history of the era. 
In a wider context, the looming threat of a nuclear war overshadowed 
the Cold War. Military and strategic considerations contributed to the 
formation of Big Science and aff ected research funding structures and 
research practices all over the world. 3 
 While the potential threat of destruction was pervasive, other 
results arising from the Second World War were equally important: 
the impact on the economy, on concepts of what citizens’ roles are, 
on beliefs in progress in medicine and science, and on concerns over 
ethical issues in medicine. Moreover, this time saw the advent of new 
international agencies, such as the WHO; an era of decolonisation; the 
establishment of new regimes; and the emergence of particular ideas 
about what modern societies should be. One of the key sites of new 
regimes that worked with particular ideas of modernity was Eastern 
Europe, where, in accordance with the Soviet Union, communist 
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governments emerged to gain exclusive political control between 1945 
and 1952. 
 One would not expect polio to play a central role in such a sett ing 
– especially since, in terms of number of people aff ected, it was not a 
major health threat. Even at the climax of an epidemic, the increased 
incidence numbers were not particularly high when compared to the 
morbidity and mortality of other diseases of the era. However, as in 
many post-war societies, population politics became increasingly 
important in Eastern Europe in the wake of long years of devastating 
and bloody batt les, deportations, genocide and starvation. Moreover, 
an intensive concentration on heavy industry and material output in the 
1950s, and an ideology that placed robust physical workers at the heart 
of communism’s success furthered interest in the reproduction of 
healthy and productive bodies. 
 Faced with the aft er-eff ects of the Second World War and the eco-
nomic goals and ideals of the new era, several states enforced a strict 
pro-natalist policy in the early 1950s, most prominently abortion bans, 4 
in the hope of increasing live births and thereby the number of pro-
ductive workers. Th e general idea and goal undergirding pro-natalist 
policies was a shared att ribute in the Eastern Bloc. As historian Gail 
Kligman put it, ‘Mobilization and control of the population were of 
critical strategic importance for the maximization of development 
potential, and att ention to demographic phenomena was essential to 
securing long-term interests. In order to meet the relatively high labor 
needs of such economies, reproduction of the labor force became a 
priority planning item.’ 5 
 In all countries of the Eastern Bloc, with the exception of Albania, 
the bans were lift ed aft er abortion was made possible on request in the 
Soviet Union in 1955. 6 Th e short increase during the years of the abor-
tion ban was soon followed by the decrease in live births. In Hungary, 
the 1956 Revolution, followed by a massive emigration of dissidents 
further added to the decrease in the current and future workforce. 7 
 Th e epidemic waves of polio came to Eastern Europe at the time of 
this demographic shock and challenged the process of social, political 
and economic reorganisation. Th e relatively new communist govern-
ments that positioned themselves as the answer to a bright and produc-
tive future, had to deal with the traumatic eff ects of polio epidemics, 
which threatened communist ideals. 
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 A disease that targeted the youngest of the population, leaving them 
physically disabled and removing them from the potential workforce 
was an eff ect that could not be taken lightly, on either sides of the Iron 
Curtain. From the communist state ’ s point of view, this eff ect was aggra-
vated when the visibly disabled bodies of polio victims were pitt ed 
against the robust bodies of workers and peasants omnipresent in 
murals, statues, magazines and schoolbooks. Polio simply did not fi t the 
communist utopia. 
 Severe polio epidemics started to appear in Eastern Europe around 
the early 1950s. In Romania, epidemics began in 1949 and peaked in 
1957 with an incidence rate of a stunning 42.5 cases per 100,000. 8 In 
Poland the most severe year was the fi rst, 1951, with an incidence rate 
of 12.7, 9 while in Hungary, where epidemics began raising concern in 
1952, the worst epidemic year of 1957 produced a relatively high inci-
dence rate in the region: 23.8 per 100,000. 10 In Bulgaria, apart from the 
epidemic year of 1941, polio began taking its toll every three years from 
1951 onwards, reaching a peak in 1957 with a morbidity rate of 13.8 per 
100,000 inhabitants. 11 An exception to the rule was Czechoslovakia, 
where 1939 marked the beginning of the polio era. 12 However, in the 
early 1950s the incidence rate reached its highest peak, rising from 1.52 
in the 1930s to 10.03 per 100,000. 13 
 Polio, primarily a disease of children, raised the stakes for the state ’ s 
provider role in public health. While health care was consistently low 
among spending priorities, and always took a backseat to the develop-
ment of heavy industry in rebuilding the country aft er the war, it was 
also one of the key elements of the communist state that set the East 
apart from the West. 
 Th e ideological stance in public health objectives, which framed 
theories of health and disease on dialectical-materialist ideas, was based 
on the post-war Soviet model of public health and was adopted in 
several Eastern European countries following the communist takeover 
around 1948. 14 As historian of medicine Bradley Moore points out, 
preventive and prophylactic interventions against external threats to 
the health of the body were key in this Eastern European thinking about 
public health. 15 Moreover, free access to health care for workers pro-
vided by the paternalistic state was a fundamental idea in how the 
system worked, or at least was supposed to work. Polio, with its debili-
tating eff ects and its patients’ need for long-term treatment, visibly 
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challenged the provider role that the state set up for itself through poli-
cies and communication. More importantly, the fact that polio aff ected 
children made it imperative to meet its challenge successfully. 
 State paternalism and socialised medicine were not unique to the 
Eastern part of Europe. In the post-war era, national health care schemes 
and states’ strong intervention in health matt ers were on the rise in 
countries such as Great Britain, France and Sweden. As Lundberg and 
Holmberg show (Chapter  10 in this book), it is a historical heritage that 
countries, like Sweden, still grapple with today. 
 However, not only was public health in general, and prevention in 
particular, a cornerstone of the communist ideal, but mass public health 
programmes, such as prevention of infectious diseases by vaccination 
were ideal terrains in which the communist state could demonstrate its 
power and legitimate its authority. If vaccination worked, the result 
would be immediate and visible. If not, factors unconnected to the state, 
like science could be blamed. 16 
 Salk vaccine behind the Iron Curtain 
 Polio vaccination in Eastern Europe became such an enterprise with 
vaccines that appeared in the West in the second half of the 1950s. As 
the incidence of the disease appeared with more frequency and with 
higher and higher rates around the world, vaccine development became 
especially pressing and therefore gained priority in securing research 
funds. Th e fi rst vaccine to be widely produced and distributed was the 
Salk vaccine in 1955, developed by Jonas Salk in the USA, which 
induced immunity to the disease with the help of inactivated or killed 
poliovirus. 
 Developing the vaccine was one important step. Establishing its effi  -
ciency was quite another. American authorities moved quickly when it 
came to approving and licensing the Salk vaccine; 17 it took them merely 
two hours aft er Th omas Francis, director of the University of Michigan 
Poliomyelitis Vaccine Evaluation Center, offi  cially announced the 
results of the fi eld trial involving 1.8 million schoolchildren on 12 April 
1954. 18 
 On 25 April 1955 in California, a child previously inoculated with 
the Salk vaccine was admitt ed to the hospital with signs of polio. Th e 
following day, fi ve similar cases were reported. All of these patients 
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received vaccine produced by the Cutt er Laboratories, and on 27 April 
the Surgeon General requested that Cutt er recall all its vaccines. In the 
course of the next two months, 94 vaccinated patients, 126 family con-
tacts and 40 community contacts were diagnosed with poliomyelitis 19 
in what would be termed the Cutt er incident. Th is situation had tre-
mendous impact: it shook public trust in the vaccine, changed vaccine 
regulation and control in the USA and ultimately aff ected the story of 
another, live-polio vaccine developed by Albert Sabin. 20 While Ameri-
can and worldwide confi dence was soon restored in the only available 
vaccine, in the following years, based on varying experience with its 
application around the world, the effi  cacy of the Salk vaccine would be 
debated at international conferences and on the pages of medical jour-
nals well into the 1960s. 
 Th ese debates did not seem to appear in the decision-making of 
Eastern European polio vaccine use. In the wake of the threat against 
the bodies of their citizens and their modernist projects, with a particu-
lar, ideological and practical emphasis on disease prevention, most 
Eastern European countries introduced the Salk vaccine without much 
public or professional deliberation. Th is set them apart from many of 
their western counterparts, where, despite intense state involvement in 
polio prevention, extensive professional debates surrounded and 
informed governments’ decisions in choosing and implementing vac-
cination strategies. 21 
 Th e timing of the introduction of polio vaccines in Eastern Europe, 
however, did follow the same patt ern as in the West: governments gen-
erally took action only when the imminent threat of a severe epidemic 
was unfolding. One of the explanations for this is that polio was not an 
omnipresent threat. It usually caused outbreaks in the summer months, 
and did not come every year. Another important aspect was the fi nan-
cial commitment vaccination required: importing vaccines was a costly 
enterprise and sett ing up domestic vaccine production required signifi -
cant investment, like building new laboratories, training staff  and 
importing and keeping expensive lab animals. 22 Th is latt er, economic 
aspect was especially important in Eastern Europe, since both vaccine 
import and the establishment of domestic production required hard 
currency that was not easy to come by. 23 
 Czechoslovakia was among the fi rst in the region to introduce inac-
tivated Salk vaccine. While preparations for local polio vaccine 
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production began in 1956, an atypical epidemic wave in that same year 
urged the government to change its original plans to start polio vaccina-
tion with domestic vaccine at the end of 1957. Instead, Czechoslovakia 
acquired vaccine from the Canadian Connaught Laboratories and 
started immunisation in the spring of 1957, before the onset of the 
epidemic season. Paediatricians and Red Cross volunteers aided the 
vaccination process. Th ey followed the so-called ‘Danish method’ of 
injecting a low vaccine dose intradermally, using 0.1 and 0.15 ml vaccine 
in two doses. 24 Th e Czechoslovak hygienists were upfront about choos-
ing this method ‘to inoculate the maximum number of children with 
the limited amount of vaccine available’. 25 A year later the Czech health 
authorities calculated the eff ectiveness of the initial vaccination cam-
paign to be 66 per cent in the Czech regions and 72 per cent in Slovakia 
for children under the age of 7. Th ey found the results to be promising 
and decided to continue vaccinations with domestically produced Salk 
vaccine in 1958. 26 However, state hygienists soon became interested in 
another vaccine developed by Sabin, turning a signifi cant part of the 
country into a fi eld-testing site. 
 Like their Czechoslovak counterpart, the Hungarian government 
chose to import Canadian and American vaccine to begin the immu-
nisation of the population in 1957. Although preparations were also 
made for domestic vaccine production, the process was signifi cantly 
delayed, mostly due to the revolution that broke out in the autumn of 
1956, while an evaluation study was being prepared. However, there 
was no time to lose, since the most severe polio epidemic in the history 
of Hungary was unfolding in the summer of 1957. Th us, mass vaccina-
tion began with the imported Salk vaccine, mostly produced by the 
Canadian Connaught Laboratories, and American manufacturers Eli 
Lilly and Co. and Parke-Davis and Co., 27 along with shipments from 
the WHO and smaller contributions from religious organisations. 28 In 
an eff ort to stretch vaccine supplies as far as possible, the Hungarian 
Health Ministry also chose the Danish method to administer the 
vaccine. Th is method, which used close to 1/10th of the conventional, 
intramuscular vaccination method came under scrutiny 29 when, despite 
the widespread vaccination campaigns, a new, severe epidemic occurred 
in 1959, with an incidence rate of 18.3 per 100,000. 30 Th is new epidemic 
also marked the end of domestic Salk vaccine production in Hungary, 
which had begun earlier that year. 31 Instead, the government decided 
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to rapidly test and then introduce Sabin ’ s new, live vaccine by the end 
of 1959. 
 Other Eastern European countries followed similar patt erns with the 
Salk vaccine. Poland began domestic production in 1957 on a small 
scale 32 and started mass production in the second half of 1958. Th e 
vaccination was to be covered partially by domestic, and partially by 
imported, Salk vaccine. 33 As in many countries, an epidemic served as 
motive for the Bulgarian government to introduce mass vaccination in 
September 1957. Bulgaria used imported vaccine until 1959 (from the 
American Merck and Connaught Laboratories), when it switched to 
the inactivated vaccine produced in the Soviet Union. 34 Th e East 
German government began vaccination with the inactivated vaccine in 
1958, using the so-called ‘Berna’ vaccine, produced by the Swiss Serum 
and Vaccine Institute in Bern. In order to spare vaccine, the East German 
method of choice was also intradermal injection. Th is method changed 
with the arrival of Salk vaccine prepared in Moscow – with the avail-
ability of larger quantities of more aff ordable vaccine, East Germany 
changed to the intramuscular injection of 1 ml vaccine for the fi rst 
dose. 35 Instead of using Salk ’ s polio vaccine, Romania began immunisa-
tion with a diff erent inactivated vaccine: the recently released Lépine 
vaccine, developed in France by Pierre Lépine, physician and biologist, 
and manufactured by the Pasteur Institute of Paris. 36 
 As the story of Eastern European Salk vaccination shows, the Iron 
Curtain did not stand in the way of polio prevention. Moreover, it 
was not only the vaccines that crossed over the fi rm border dividing 
West from East. Eastern European scientists were regular participants 
in the international (European and global) conferences on poliomyeli-
tis, exchanging experiences with vaccination and research on the polio 
vaccine. In addition, since Salk vaccine production required a particular 
and strict procedure, along with elaborate laboratory equipments and 
the keeping of live monkeys, Eastern European virologists and public 
health specialists crossed to western countries like Denmark and Sweden 
to gain experience in inactivating the virus and producing the vaccine. 37 
 Sabin vaccine and the Eastern European trials 
 Th e scientifi c interaction across the Iron Curtain continued with the 
development, testing and implementation of the Sabin vaccine. Th e 
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novelty of the new vaccine was that instead of containing killed virus, 
it aimed to achieve immunity with the presence of live, att enuated virus 
– that is, poliovirus that had been suffi  ciently weakened so as not to 
cause illness, but potent enough to elicit an immune response. Like wild 
poliovirus strains, the att enuated strains were also excreted by the vac-
cinees, creating the possibility of indirectly immunising people who 
had not been vaccinated. Th e live virus vaccine was also diff erent from 
the Salk in another important way: it could be administered orally, 
instead of by injection. 
 Live poliovirus vaccine was never tested on a mass scale in the USA, 
for several reasons. First, with the widespread use of the Salk vaccine, 
the main funding body of polio prevention and care, the National Foun-
dation for Infantile Paralysis, along with US authorities, lost interest in 
investing greatly in yet another vaccine. Moreover, aft er the Cutt er inci-
dent, they were wary of embarking on a potentially risky polio vaccine 
trial. 38 Th erefore, live poliovirus trials were, for the most part, con-
ducted outside the USA. 
 Th e history of live poliovirus vaccines has been mostly explored 
through the Cold War cooperation between the American Albert Sabin 
and the Russian Mikhail Chumakov. 39 Th e common pursuit of these 
two scientists led to the largest fi eld trial in the history of polio vaccina-
tion, involving almost 17 million people in the Soviet Union. 40 As soon 
as Sabin fi nished selecting the most optimal strain for creating the 
vaccine, he sent samples to Anatol Smorodintsev, Chumakov ’ s col-
league in Leningrad. Field trials with the strain started in 1957 on a very 
small scale with the vaccination of 67 children. Th is number gradually 
grew to 150, then to 2,010, and fi nally to 20,000 in 1958. 41 Parallel to 
Smorodintsev ’ s trials, another fi eld trial, initiated by Chumakov, then 
director of the Poliomyelitis Research Institute in Moscow, took off  in 
greater proportions. Chumakov asked Sabin to send him ‘the greatest 
possible amount’ of vaccine for testing and producing. Sabin sent 
enough to vaccinate 300,000 children. 42 Chumakov started the trial 
with 20,000 and, following its initial success, was able to conduct the 
largest fi eld trial to date in the history of polio vaccines. 
 By the end of 1959, over 15 million people spanning fourteen repub-
lics of the Soviet Union were vaccinated in the trial. Smorodintsev and 
his team immunised more than 1.5 million of the subjects; the rest 
received vaccine from Chumakov ’ s lab in the Institute for Poliomyelitis 
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Research in Moscow. Th e Soviet Union ’ s Minister of Health issued an 
order on 16 December 1959 for the mass immunisation of the whole 
population between the ages of two months and 20 years by July 1960. 
Th is meant vaccinating 77 million people in a matt er of months. 43 Th e 
 British Medical Journal deemed this campaign a ‘Blitzkrieg against 
poliomyelitis’. 44 
 However, the story of further Eastern European trials, equally impor-
tant to their Soviet counterparts, remains largely unexplored. Live vac-
cines fared even worse than the Salk vaccine in creating consensus in 
vaccine effi  ciency, and more importantly, safety. Fears that vaccines 
made with att enuated live viruses could cause or spread disease instead 
of curbing epidemics were persistent throughout the development of 
the live vaccines in the 1950s and the early 1960s. Trials in Eastern 
Europe became important reference points in vaccine effi  ciency and 
safety considerations both in scientifi c debates and in governments’ 
decision-making processes on the introduction of the vaccine. 
 Th e Hygiene and Epidemiological Service of Czechoslovakia organ-
ised relatively large fi eld trials in 1958 and 1959 with vaccines prepared 
from the Sabin strains by the Institute of Sera and Vaccines in Prague, 
with additional batches of vaccines acquired from Chumakov in the 
Soviet Union. 45 
 Sabin, whose help the Czechoslovak scientists requested through the 
WHO, 46 personally aided the bureaucratic process of shipping the 
strains from Cincinatt i to Prague in the spring of 1958 and kept a close 
eye on the trials. 47 Th e trials were conducted in four regions (Ústi nad 
Labem, Liberec, Juhlava and Ostrava) 48 and in total 140,000 children 
between the ages of 2 and 6 were vaccinated. 49 
 Finding the serological results favourable, and based on studies by 
mostly Soviet scientists, 50 the vaccination programme was extended 
nationwide in 1960. Using domestically produced vaccine from Sabin 
strains and also vaccine imported from the Soviet Union, 51 93 per cent 
of Czechoslovakia ’ s child population was vaccinated, roughly 3.5 million 
children between the ages of two months and fourteen years. 52 Th e 
mass vaccination was deemed to be an instant success: no confi rmed 
poliomyelitis cases developed in the territory of Czechoslovakia in the 
fi rst two epidemic seasons aft er the beginning of the campaign. 53 
 Although less widely known than the fi eld trials and early mass-
immunisation programmes in the Soviet Union and Czechoslovakia, 
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Hungary was also among the Sabin vaccine pioneers. A growing disil-
lusionment with the inactivated vaccine initiated a switch to Sabin ’ s live 
poliovirus vaccine, making Hungary the fi rst country in the world to 
begin mass immunisation with the new vaccine on a national level in 
early December 1959. 54 Hungarian virologists and public health author-
ities had been following oral vaccination trials closely throughout the 
year, and some had been in touch with Albert Sabin personally, meeting 
regularly at conferences and sharing results. 55 A turning point in devel-
oping serious interest came with the epidemic of the summer of 1959. 
Trials with vaccine imported from the Soviet Union began in Gy ő r-
Moson-Sopron County in 1959 on 3 and 4 November, during which 
the population between the ages of three months and fi ft een years 56 was 
vaccinated. Virologists reported the average acceptance rate of the 
vaccine to be 96 per cent. 57 
 Th e trial was short, and not much time was spent on evaluating the 
results. Th e National Public Health Institute analysed 127 stool samples 
before and aft er the trial to investigate the presence of the att enuated 
virus aft er vaccination; but the overall evaluation of the vaccine and the 
decision to introduce the vaccine was based on the large-scale fi eld 
trials conducted by the Soviet Union, as well as the experiences of 
Czechoslovakia and Singapore with the Sabin, and Poland and the 
Belgian Congo with the Koprowski strains. 58 Hungarian virologists, in 
this sense, drew on an international experiences with live vaccines that 
not only crossed the dividing lines of the Cold War, but also spanned 
across continents. Th ey were able to do so thanks to access to interna-
tional journals and a continuous presence at international polio confer-
ences and symposiums. 
 On 14 December 1959, nationwide vaccination in Hungary began 
with the Sabin drops. Immunisation was mandatory for children 
between three months and two years; for all other age groups, the 
immunisation was voluntary. 59 Vaccination was organised in Mother 
and Infant Protection Offi  ces by the district paediatricians. Children 
were also vaccinated in day care sett ings, kindergartens and schools, 60 
which renders the term  voluntary dubious. By 1960, Hungary had vac-
cinated 2.5 million people, more than the total in the two years of Salk 
vaccination. Th e country thus joined the Soviet Union and Czechoslo-
vakia in being the fi rst countries in the world to organise mass vaccina-
tion with the new, live -poliovirus vaccine. 
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 East Germany followed suit with a fi eld trial of the Sabin vaccine in 
April 1960, citing the favourable results in the Soviet Union, Czecho-
slovakia, Hungary and Poland as the basis for their own trial. Th e vac-
cination was free and voluntary, and German virologists reported a very 
favourable public acceptance, immunising around 86 per cent of the 
people between the ages of two months and twenty years. Vaccination 
with the oral vaccine became compulsory in 1961, reaching 43 per cent 
of the total population by 1962. 61 
 It is important to note another large-scale fi eld trial conducted in 
Poland, using Hilary Koprowski ’ s live poliovirus vaccine. Th e vaccina-
tion began with a small-scale vaccination in October 1958, involving a 
total population of 8,716 in a small town and three villages. In the next 
step, aft er approval from the special committ ee appointed by the Min-
istry of Health, all children between the ages of six months and fi ft een 
years were immunised with the type 1 (Chat) strain in two provinces, 
Krakow and Opole, totalling 643,000 people. 62 Beginning in autumn 
1959, in a mass immunisation campaign, over 7 million people, mostly 
children, received type 1 (Chat) and type 3 (Fox) strains. By the end 
of 1960, 26 per cent of the total population was immunised with oral 
vaccine, including 76 per cent of children between the ages of six 
months and fi ft een years. 63 Based on the decrease of the incidence rate 
of epidemics, Polish virologists determined the vaccine ’ s effi  cacy to be 
82.9 per cent. 64 
 Mass vaccination campaigns with the live poliovirus vaccine soon 
followed in the rest of Eastern Europe: in Bulgaria in 1960, targeting 
about two million children between two months and fourteen years of 
age; 65 in Romania in 1961, administered to the whole population under 
the age of 30: around ten million people. 66 Yugoslavia carried out a 
small fi eld trial with the Sabin vaccine from January to May 1960, 
involving about eight thousand pre-school children in the city of Kragu-
jevac, and, following a relatively severe epidemic in 1960, began mass 
vaccination in 1961. 67 
 Eastern European governments and the West alike saw the fi eld trials 
and mass vaccinations in the region as something particular to com-
munist states. On the one hand, participant states in the fi eld trials and 
early mass vaccination campaigns saw the success in dramatically 
curbing polio as ultimate proof of the superiority of their ideological 
and political system. On the other hand, for many researchers and 
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public health offi  cials of the West, intensive, mass fi eld trials and vac-
cination campaigns, such as the ones conducted in Eastern Europe and 
the Soviet Union were inextricably connected with authoritarianism 
inherent in communist states. 
 As polio cases began to plummet, communist states were quick to 
claim credit. Th is was especially true for the two countries leading vac-
cination eff orts with the Sabin vaccine. Hungary emphasised the 
importance of the overall communist enterprise in the success of the 
Sabin vaccine. 
 At fi rst, offi  cial communication on the Sabin vaccination re-evaluated 
the state ’ s role in vaccine procurement. In the case of the Salk vaccine, 
the government was portrayed as a hero, which, in spite of all hardships 
and even running into debt, managed to go out there and get much 
needed protection for children. 68 Th is time, the signifi cance of outside 
help was emphasised, having arrived from the right side of the Iron 
Curtain: according to daily newspaper Népszava, the Hungarian gov-
ernment. ‘asked for the help of the Soviet Union and not without result: 
We were granted 2.5 million doses of vaccine’. 69 Th ere was no talk of 
cost or debt or the feat of the state required to import the vaccine. Later, 
communist offi  cials contrasted the polio-free world of Eastern Europe 
with struggling western nations, who, for the sake of free trade and 
economic hardships were reluctant to switch to the Sabin vaccine and 
thus were still experiencing polio epidemics. 70 
 Czechoslovak scientists and public health offi  cials chose to empha-
sise their own contribution to vaccine development and the role of the 
communist state in the project. Vilém Škovránek, chief hygienist, 
clearly declared the achievement of the Czechoslovak polio prevention 
strategy to be an evidence of good governing: ‘Th e success of the mass 
vaccination was a proof of the highly developed organizing abilities of 
the Czechoslovak Ministry of Health and the profound understanding 
of our people for health problems. Th e vaccination campaign was 
accomplished without any particular troubles and the att endance of the 
population was very high.’ 71 
 Th e Czechoslovak sentiments highlight two important aspects of 
Eastern European polio vaccination campaigns in the Cold War: the 
question of voluntarism and the advantages of the authoritarian organi-
sation of state and public health. First, as Škovránek emphasised, the 
fact that citizens happily volunteered for trials and readily complied 
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with mass vaccination campaigns was crucial in the representation of 
successful public health interventions, and not only in Czechoslovakia. 
Th is fi tt ed very well with western stereotypes of Eastern European citi-
zens being either oppressed by the communist state or being uniform, 
obedient subjects. 
 However, it is very diffi  cult to discover how voluntary and compliant 
the Eastern European population actually was. Offi  cial communication 
on vaccination hardly ever touched on problems or signifi cant chal-
lenges, only when unexpected epidemic crises unfolded, did criticism 
and reluctance surface. Such a case was the 1959 epidemic in Hungary, 
when the government accused parents of carelessness and scolded 
them for not vaccinating their children. 72 Reports reveal that some 
parents did not trust the new vaccine and their distrust was shared with 
some physicians as well. 73 Since the debacle of 1959 was almost cer-
tainly not exclusively caused by low immunisation rates, 74 it is not clear 
if large numbers of parents were involved, or if they only became visible 
as a possible explanation as the government was trying to make sense 
of an inexplicable situation. 
 Second, the military-like organisation of preventive public health 
measures, such as vaccination and the compulsory participation of the 
population in such enterprises rang alarm bells in the immediate post-
war years. In the wake of a horrible war against the Nazi dictatorship 
that organised itself with utmost effi  ciency, and with the looming threat 
of Soviet totalitarianism, engaging with anything remotely authoritar-
ian caused uneasiness in the West when contemplating public health 
measures. Already in 1948 such sentiments were articulated at the First 
International Poliomyelitis Conference, where one participant pointed 
out the tensions between the legacy of dictatorships and the most eff ec-
tive ways of preventing and controlling disease through autocratic 
measures. 75 Th e merit of a high level of state authority in successfully 
implementing public health policies, especially in times of epidemics, 
and the frustrations this perception caused in Cold War thinking 
became a recurring issue in the history of polio. 
 Reservations about autocratic regimes, disease prevention and sci-
entifi c knowledge production came to the forefront during the evalua-
tion of the Soviet fi eld trials in 1959. Th e American virologist, Dorothy 
Horstmann, representing the WHO in the assessment of the validity of 
the trials highlighted the role of a centralised and state-operated public 
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health system in successfully organising such an endeavour. In her 
report, Horstmann spoke of live virus vaccination programmes and the 
Eastern European, military-like organisation of public health as being 
‘peculiarly fi tt ed’. 76 In the Soviet case, a state and health care system that 
was centrally controlled top-down seemed ideal in organising a project 
on a mass scale and at the same time guaranteed that such scientifi c 
trials would be meticulous. 
 Conclusion 
 For the relatively young communist governments, polio pitt ed specifi c 
challenges to ideas of state paternalism, which permeated health care 
policies, in a decade that was burdened by Cold War thaws and frosts 
and revolutions. Th e stakes did not only regard the health of the popula-
tion and epidemic control, but also the strength and capability of the 
new communist system. 
 Both East and West shared the perception of what the communist 
state was and its ideal role in polio prevention. Following the appear-
ance and successful application of live poliovirus vaccines, Eastern 
European states saw themselves as particularly suited to achieve eff ec-
tiveness in curbing – and eradicating – polio through their part in 
vaccine development and its distribution. Th e West, while not endors-
ing such political regimes ideologically, agreed. Indeed, Czechoslova-
kia, Hungary and Poland became pioneers in introducing, testing and 
applying live poliovirus vaccines on a mass scale, while their Eastern 
European peers were quick to follow in mass vaccination. 
 From a broader geopolitical perspective, polio raised uncomfortable 
questions about the positive side of communist regimes (i.e. eff ective 
epidemic control) and in a short time came to symbolise ‘neutral’ 
science that broke the barriers between East and West. Th e top-down 
organisation of vaccine trial organisation and immunisation, which 
was, at the time, seen as particularly communist and Eastern European, 
also came to be seen as the most eff ective way to eradicate polio on 
a global scale. 
 Eastern European trials and the mass vaccination methods applied 
in communist countries became reference points in scientifi c discus-
sions on the safety and effi  cacy of the Sabin vaccine. Th e mass vaccina-
tion strategies developed in Hungary, Cuba and later in Brazil became 
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models for the global polio eradication programme of the WHO. 77 Th e 
long-term eff ects of Eastern European states’ role in live virus vaccine 
development and disease elimination carried the legacies of how com-
munist states worked and the way in which they were imagined, over 
the boundaries of Europe and beyond the Cold War to global epidemic 
management strategies of the present. 
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